"Eosinophils" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.
| Descriptor ID |
D004804
|
| MeSH Number(s) |
A11.118.637.415.345 A11.627.340.345 A15.145.229.637.415.345 A15.382.490.315.251
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Eosinophils".
Below are MeSH descriptors whose meaning is more specific than "Eosinophils".
This graph shows the total number of publications written about "Eosinophils" by people in this website by year, and whether "Eosinophils" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 2 | 2 | 4 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 3 | 4 |
| 2017 | 3 | 1 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 5 | 2 | 7 |
| 2020 | 3 | 7 | 10 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 2 | 2 |
| 2023 | 1 | 4 | 5 |
| 2024 | 3 | 1 | 4 |
| 2025 | 3 | 3 | 6 |
| 2026 | 3 | 4 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Eosinophils" by people in Profiles.
-
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies. Eur J Clin Invest. 2026 Oct; 56(10):e70256.
-
Associations of Meal-Related and Somatic Symptoms With Mucosal Eosinophil and Mast Cell Counts in Youth With Disorders of Gut-Brain Interaction. Neurogastroenterol Motil. 2026 Aug; 38(8):e70406.
-
Inhibitory effect of the water-soluble retinoid X receptor partial agonist CAt-PMN on allergic conjunctivitis-like responses in mice. Exp Eye Res. 2026 Sep; 270:111131.
-
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2026 Aug; 11(8):672-688.
-
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. Lancet. 2026 May 23; 407(10543):2027-2039.
-
Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers. Chest. 2026 Jun; 169(6):1464-1475.
-
Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study. Int J Chron Obstruct Pulmon Dis. 2026; 21:562498.
-
Persistent airway obstruction in severe eosinophilic asthma: targeting interleukin-5 and eosinophils. Eur Respir Rev. 2025 Oct; 34(178).
-
N-acetyl-L-alanine ameliorates atopic dermatitis-like symptoms by suppressing Th2 differentiation in DNFB-induced NC/Nga mice. BMB Rep. 2025 Oct; 58(10):437-443.
-
Physiological Level of Eosinophils Is Essential for the Regeneration and Homeostasis of Murine Hematopoietic Stem Cells. Allergy. 2026 May; 81(5):1749-1762.